Susquehanna International Group, LLP Anavex Life Sciences Corp. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 1,134,738 shares of AVXL stock, worth $9.67 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,134,738
Previous 238,417
375.95%
Holding current value
$9.67 Million
Previous $1.35 Million
800.07%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding AVXL
# of Institutions
182Shares Held
28.9MCall Options Held
749KPut Options Held
825K-
Black Rock Inc. New York, NY6.39MShares$54.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.68MShares$39.9 Million0.0% of portfolio
-
State Street Corp Boston, MA2.41MShares$20.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.87MShares$16 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA913KShares$7.78 Million0.62% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $664M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...